Horudhac Qaybta Oncology, immunotherapy waxay u soo baxday hab horudhac ah, oo ka faa'iidaysanaysa habka difaaca jidhka si loola dagaallamo burooyinka halista ah. Waxaa jira habab badan oo difaaca jirka ah, laakiin Chimeric Antigen Rece.
Juun 2022: Laba ama in ka badan oo daawaynta habaysan ka dib, FDA waxay siisay tisagenlecleucel (Kymriah, Novartis Pharmaceuticals Corporation) oo dadajisay oggolaanshaha bukaanada qaangaarka ah ee dib u soo noqday ama dib u soo noqday follicular lymphoma (FL).T.
Maarso 2022: Habka kacaanka ee daawaynta unug ee CAR-T waxay awood u leedahay inay rogaan waxa noqday axiom caafimaad: in daawaynta saamaynta cajiibka leh ee burooyinka ay ku timaaddo kharashyada khataraha la taaban karo ee bukaan socodka.
Immunotherapy ee daawaynta kansarka Kansarka CAR-NK waxay leedahay heer wax ku ool ah oo ah 73%, waxaana lagu qorayaa tijaabooyinka kiliinikada gudaha. Kansarka difaaca jirka waa kala qaybsanaan.
Julaay 2021: Eeg dawooyinkii ugu dambeeyay ee daawaynta kansarka. Sannad kasta, ka dib marka la eego tijaabooyinka iyo arrimo kale oo muhiim ah, USFDA waxay ansixisay daawooyinka, sidaas awgeed bukaannada kansarka waxay hadda rumaysan karaan in daawadu aad u dhowdahay. ..